Review: Retraction notice: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Review: Retraction notice: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

A retraction notice was published regarding the study titled: “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,” which appeared in The Lancet on May 22nd. 

  • Concerns about the data were raised and the authors launched an independent third-party peer review of the source of the data, held by Surgisphere
  • Surgisphere refused to transfer the full data set, leading to their withdrawal of the paper
  • The authors also used Surgisphere for a data set published in NEJM, which is also being retracted
  • Of note: this study had found increased frequency of ventricular arrhythmia and in-hospital mortality, causing a temporary halt of its use within a large study, called SOLIDARITY trial, by the World Health Organization.

|2020-06-05T11:23:51-04:00June 4th, 2020|COVID-19 Literature|Comments Off on Review: Retraction notice: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

About the Author: CTSI Author

CTSI Author

Get Involved with Indiana CTSI